Torniainen Minna, Suvisaari Jaana, Partonen Timo, Castaneda Anu E, Kuha Annamaria, Suokas Jaana, Perälä Jonna, Saarni Samuli I, Lönnqvist Jouko, Tuulio-Henriksson Annamari
Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland.
J Nerv Ment Dis. 2012 Apr;200(4):316-22. doi: 10.1097/NMD.0b013e31824cb359.
The present study aimed to compare population-based familial samples of patients with schizophrenia (n = 218) and schizoaffective disorder (n = 62) and a healthy control group (n = 123). Patients with schizoaffective disorder outperformed patients with schizophrenia in verbal ability, processing speed, visual working memory, and verbal memory. When compared with controls, patients with schizoaffective disorder also had a generalized cognitive impairment. Adjusting for clinical characteristics removed significant differences between the patient groups. Irrespective of the diagnosis, patients with the most severe negative symptoms and highest dose of antipsychotics had the most severe cognitive impairments, whereas mood symptoms were not related to cognitive performance. In conclusion, people with schizoaffective disorder have severe cognitive impairments, but the impairments are milder than in schizophrenia. Mood symptoms may not explain the difference between the diagnostic groups in cognitive functions, but the difference may be related to differences in the severity of negative symptoms.
本研究旨在比较基于人群的精神分裂症患者(n = 218)、分裂情感性障碍患者(n = 62)和健康对照组(n = 123)的家族样本。分裂情感性障碍患者在语言能力、处理速度、视觉工作记忆和语言记忆方面的表现优于精神分裂症患者。与对照组相比,分裂情感性障碍患者也存在广泛性认知障碍。调整临床特征后,患者组之间的显著差异消失。无论诊断如何,具有最严重阴性症状和最高剂量抗精神病药物的患者认知障碍最严重,而情绪症状与认知表现无关。总之,分裂情感性障碍患者存在严重的认知障碍,但比精神分裂症患者的障碍程度较轻。情绪症状可能无法解释诊断组在认知功能上的差异,但这种差异可能与阴性症状严重程度的差异有关。